Kris Jacobs Vacancies Kris Jacobs Kris Jacobs Loading jobs... Stay updated Sign up to stay updated and find out how you can get involved. Email Address Data protection consent Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Photo credit: MSF Press release Press release | 23 July 2024 HIV/AIDS Activists at AIDS2024 Demand: Break Gilead’s Lenacapavir Monopoly Gilead’s Price 100,000% Higher than Target Generic Price for 100% Effective Prevention Shot 3 min Blog Blog | 19 July 2024 Tuberculosis AfricaSierra Leone Sierra Leone: New approach radically improves diagnosis and treatment of children with TB Press release Press release | 17 July 2024 Tuberculosis MSF welcomes Indian Patent Office’s rejection of J&J’s application for paediatric formulation of lifesaving TB drug 4 min Photograph by Mariana Abdalla Statement Statement | 16 July 2024 Pandemic preparedness Pandemic Agreement: MSF Statement at INB10 2 min Press release | 05 July 2024 Intellectual property and trade Tuberculosis South Africa MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in South Africa Blog Blog | 28 June 2024 Antimicrobial resistance Bridging the access gap to microbiology diagnostics is a critical part of the global response to antimicrobial resistance (AMR) Report | 26 June 2024 Transparency Secrets Cost Lives: Transparency and Access to Medical Products Letter Letter | 25 June 2024 Diagnostics Time for $5 campaign: Open letter to Danaher employees Load More
Photo credit: MSF Press release Press release | 23 July 2024 HIV/AIDS Activists at AIDS2024 Demand: Break Gilead’s Lenacapavir Monopoly Gilead’s Price 100,000% Higher than Target Generic Price for 100% Effective Prevention Shot 3 min
Blog Blog | 19 July 2024 Tuberculosis AfricaSierra Leone Sierra Leone: New approach radically improves diagnosis and treatment of children with TB
Press release Press release | 17 July 2024 Tuberculosis MSF welcomes Indian Patent Office’s rejection of J&J’s application for paediatric formulation of lifesaving TB drug 4 min
Photograph by Mariana Abdalla Statement Statement | 16 July 2024 Pandemic preparedness Pandemic Agreement: MSF Statement at INB10 2 min
Press release | 05 July 2024 Intellectual property and trade Tuberculosis South Africa MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in South Africa
Blog Blog | 28 June 2024 Antimicrobial resistance Bridging the access gap to microbiology diagnostics is a critical part of the global response to antimicrobial resistance (AMR)
